The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jun. 13, 2017
Filed:
Nov. 17, 2010
Volker Schulze, Bergfelde, DE;
Marcus Koppitz, Berlin, DE;
Dirk Kosemund, Berlin, DE;
Hartmut Schirok, Langenfeld, DE;
Benjamin Bader, Berlin, DE;
Philip Lienau, Berlin, DE;
Antje Margret Wengner, Berlin, DE;
Hans Briem, Berlin, DE;
Simon Holton, Berlin, DE;
Gerhard Siemeister, Berlin, DE;
Stefan Prechtl, Berlin, DE;
Ulf Bömer, Glienicke, DE;
Volker Schulze, Bergfelde, DE;
Marcus Koppitz, Berlin, DE;
Dirk Kosemund, Berlin, DE;
Hartmut Schirok, Langenfeld, DE;
Benjamin Bader, Berlin, DE;
Philip Lienau, Berlin, DE;
Antje Margret Wengner, Berlin, DE;
Hans Briem, Berlin, DE;
Simon Holton, Berlin, DE;
Gerhard Siemeister, Berlin, DE;
Stefan Prechtl, Berlin, DE;
Ulf Bömer, Glienicke, DE;
BAYER INTELLECTUAL PROPERTY GMBH, Monheim, DE;
Abstract
The present invention relates to triazolopyridine compounds of general formula (I) which are Monopolar Spindle 1 kinase (Mps-1 or TTK) inhibitors: Formula (I), in which R, R, R, R, and Rare as given in the description and in the claims, to methods of preparing said compounds, to pharmaceutical compositions and combinations comprising said compounds, to the use of said compounds for manufacturing a pharmaceutical composition for the treatment or prophylaxis proliferative of diseases, as well as to intermediate compounds useful in the preparation of said compounds.